Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries. Read More
The first batch of Sputnik vaccine is expected to be produced at Serum Institute of India (SII)'s facilities in September, said Russian Direct Investment Fund (RDIF), the country's sovereign wealth fund on Tuesday. ...
World Health Organisation (WHO) chief scientist Soumya Swaminathan on Friday said 15 countries in the European Union (EU) now recognise Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford Universi ...
Charge d'affaires of Belgium Embassy Arnaud Lion on Friday said that recognition of Covishield by his country will have a positive impact for everyone getting the vaccine shot in India and abroad. ...
Belgium has recognised the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University, said the Embassy of Belgium in India on Friday. ...
Union Minister Mansukh Mandaviya on Friday visited a vaccine manufacturing plant of the Serum Institute of India in Pune to review the production of vaccines. ...
People often cannot choose what vaccine they get and a vaccine should not put a person at disadvantage if it is approved and is in use, Estonia Ambassador to India Katrin Kivi said on Friday. ...
